Form EFFECT KalVista Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 16, 2026 |
| Accession Number: | 0001193125-26-267506 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NASA Postdoctoral Program Seeks Early Career and Senior Scientists for Prestigious Fellowships at Its Locations Across the U.S.
- HITN presents Townhall Los niños y el tiempo en pantalla: A Practical Guide for Hispanic Families on Healthy Screen Time in Early Childhood
- Beverly Hills Plastic Surgeon Dr. David Sayah Reports Growing Demand for Breast Implant Removal and BBL Reversal
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
